Ascendis Pharma

Contributing Author

Recent Articles by Ascendis Pharma

Jun-09	TransCon hGH Boosted Treatment Benefits of TransCon CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial ASND GlobeNewswire
Jun-02	FDA Accepts TransCon CNP NDA for Priority Review ASND GlobeNewswire
May-13	New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon CNP (Navepegritide) ASND GlobeNewswire
May-12	New 4-Year Data Shows Sustained Response to TransCon PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism ASND GlobeNewswire
May-05	Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025 ASND GlobeNewswire
May-01	Ascendis Pharma Reports First Quarter 2025 Financial Results ASND GlobeNewswire